<DOC>
	<DOCNO>NCT01106391</DOCNO>
	<brief_summary>This study multi-center prospective , open label , non-randomized investigation INCRAFT™ subject abdominal aortic aneurysm . The study enroll 60 subject 7 site Germany Italy .</brief_summary>
	<brief_title>A MULTICENTER , OPEN LABEL , PROSPECTIVE , NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS ( INNOVATION )</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Subject male infertile female &gt; 18 year age 2 . Subject understands study requirement treatment procedure agree sign informed consent form prior study procedure . 3 . Subject consider appropriate candidate open surgical repair abdominal aortic aneurysm . 4 . Subject least one following : 1 . Abdominal aortic aneurysm ≥4.5 cm woman ≥ 5 cm men diameter 2 . Aneurysm , &gt; 4 cm increase size 0.5 cm within 6 month 3 . The maximum aortic diameter ≥1.5 time reference aortic diameter 4 . Saccular aneurysm 5 . Subject access vessel size compatible vascular access technique potential accessory use delivery profile 14Fr 6 . Subject aortic aneurysm neck ≥15 mm length 7 . Subject iliac landing zone≥10mm length 8 . Subject distal iliac land site diameter range 918mm 9 . Subject proximal aortic attachment 2027 mm diameter . 10 . Subject minimum overall AAA treatment length ( low renal artery distal land zone ) 140 mm . 11 . Subject willing comply specify followup evaluation . EXCLUSION CRITERIA : 1 . Subject one following : 1. dissect inflammatory aneurysm 2. acutely rupture aneurysm 3. pararenal leak aneurysm 2 . The suprarenal aorta 2cm low renal aorta nominal diameter aortic bifurcate prosthesis 3 . Aortic length ( low renal artery origin aortic bifurcation ) &lt; 8.7 cm 4 . Circumferential thrombosis and/or calcification ≥50 % aortic iliac land zone 5 . Circumferential thrombosis and/or calcification ≥50 % suprarenal aorta 6 . Subject aneurysm neck angulation &gt; 60° suprarenal and/or infrarenal location 7 . Aortic bifurcation ≤18mm diameter 8 . Acute vascular injury due trauma 9 . Subject know allergy contrast medium 10 . Subject know allergy nitinol , PET PTFE 11 . Subject need emergent surgery 12 . Subject contraindication undergo angiography 13 . Subject thoracic aortic aneurysm require treatment 14 . Subject Infrarenal aortic dissection 15 . Subject Iliac anatomy would require occlusion internal iliac artery 16 . Subject congenital abnormality placement stentgraft cause occlusion major arterial flow . Such abnormality evaluate ( e.g . angiography CT ) prior treatment 17 . Subject unstable angina define Braunwald angina classification 18 . Subject morbid obesity ( BMI &gt; 40.0 ) clinical condition severely inhibit visualization aorta 19 . Subject connective tissue disease ( e.g. , Marfan 's Ehler'sDanos syndrome ) 20 . Subject know bleeding hypercoagulable disorder 21 . Subject contraindication anticoagulation 22 . Subject Stroke MI intracranial bleeding within 3 month prior procedure 23 . Subject renal insufficiency ( creatinine &gt; 2.0 mg/dl ) 24 . Subject know suspect active infection time index procedure ( ex . Pneumonia , acute virus infection , contaminate wound etc ) 25 . Subject currently take systemic immunosuppressant therapy 26 . Subject major surgical procedure within 30 day prior procedure plan within 30 day post procedure 27 . Subject life expectancy le 2 year 28 . Subject currently participate another research study involve investigational device new drug 29 . Other medical , social , psychological issue opinion investigator preclude receive treatment , procedure evaluation pre posttreatment 30 . Subject exist AAA surgical graft and/or AAA stentgraft system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Abdominal aortic aneurysm</keyword>
	<keyword>AAA</keyword>
	<keyword>Safety</keyword>
	<keyword>Performance</keyword>
	<keyword>Stent graft system</keyword>
	<keyword>First Human</keyword>
	<keyword>Endovascular repair</keyword>
</DOC>